Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 87 | 2024 | 5130 | 9.220 |
Why?
|
Cognition Disorders | 41 | 2024 | 3980 | 4.230 |
Why?
|
Cognition | 57 | 2024 | 7073 | 2.730 |
Why?
|
Neuropsychological Tests | 56 | 2024 | 7140 | 2.420 |
Why?
|
Schizophrenia | 52 | 2023 | 6983 | 2.260 |
Why?
|
Schizophrenic Psychology | 23 | 2019 | 1649 | 1.820 |
Why?
|
Nootropic Agents | 5 | 2021 | 159 | 1.270 |
Why?
|
Social Behavior | 4 | 2019 | 1147 | 1.180 |
Why?
|
Depressive Disorder, Major | 8 | 2024 | 4818 | 0.970 |
Why?
|
Dopamine Agonists | 4 | 2021 | 347 | 0.880 |
Why?
|
Endophenotypes | 3 | 2013 | 259 | 0.820 |
Why?
|
Psychotic Disorders | 13 | 2022 | 3276 | 0.770 |
Why?
|
Lithium | 3 | 2023 | 600 | 0.760 |
Why?
|
Siblings | 3 | 2017 | 828 | 0.730 |
Why?
|
Social Perception | 2 | 2014 | 434 | 0.700 |
Why?
|
Personal Satisfaction | 1 | 2024 | 643 | 0.670 |
Why?
|
Impulsive Behavior | 5 | 2019 | 345 | 0.670 |
Why?
|
Affect | 6 | 2022 | 1495 | 0.660 |
Why?
|
Cyclothymic Disorder | 2 | 2020 | 42 | 0.640 |
Why?
|
Human Activities | 1 | 2019 | 26 | 0.640 |
Why?
|
Affective Symptoms | 2 | 2019 | 418 | 0.640 |
Why?
|
Intelligence | 5 | 2018 | 926 | 0.630 |
Why?
|
Emotions | 8 | 2023 | 2767 | 0.600 |
Why?
|
Decision Making | 10 | 2019 | 3953 | 0.600 |
Why?
|
Verbal Learning | 3 | 2017 | 465 | 0.580 |
Why?
|
Adult | 86 | 2024 | 223646 | 0.510 |
Why?
|
Sensation | 1 | 2017 | 336 | 0.500 |
Why?
|
Morals | 1 | 2018 | 288 | 0.500 |
Why?
|
Mood Disorders | 6 | 2022 | 1129 | 0.500 |
Why?
|
Memory, Short-Term | 6 | 2022 | 1008 | 0.500 |
Why?
|
Humans | 157 | 2024 | 768166 | 0.500 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2018 | 301 | 0.470 |
Why?
|
Antipsychotic Agents | 8 | 2023 | 3081 | 0.430 |
Why?
|
Carrier Proteins | 6 | 2010 | 4937 | 0.420 |
Why?
|
Catechol O-Methyltransferase | 3 | 2017 | 251 | 0.420 |
Why?
|
Awareness | 1 | 2017 | 654 | 0.420 |
Why?
|
Psychotropic Drugs | 3 | 2014 | 881 | 0.420 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3858 | 0.410 |
Why?
|
Clinical Trials as Topic | 4 | 2018 | 8054 | 0.410 |
Why?
|
Middle Aged | 61 | 2024 | 223492 | 0.400 |
Why?
|
Male | 92 | 2024 | 364719 | 0.390 |
Why?
|
Genotype | 13 | 2013 | 13045 | 0.390 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2013 | 952 | 0.380 |
Why?
|
Memory Disorders | 2 | 2017 | 1200 | 0.370 |
Why?
|
Benzothiazoles | 2 | 2011 | 248 | 0.370 |
Why?
|
Obsessive-Compulsive Disorder | 4 | 2020 | 1508 | 0.370 |
Why?
|
Polymorphism, Single Nucleotide | 21 | 2019 | 16045 | 0.370 |
Why?
|
Female | 92 | 2024 | 397192 | 0.370 |
Why?
|
Depression | 9 | 2024 | 8230 | 0.370 |
Why?
|
Cluster Analysis | 4 | 2020 | 2732 | 0.350 |
Why?
|
Nerve Tissue Proteins | 6 | 2011 | 4413 | 0.350 |
Why?
|
Oxytocin | 1 | 2014 | 404 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 23 | 2023 | 18065 | 0.340 |
Why?
|
Pharmacogenetics | 3 | 2023 | 683 | 0.340 |
Why?
|
Suicide, Attempted | 3 | 2019 | 1409 | 0.340 |
Why?
|
Antidepressive Agents | 4 | 2023 | 2913 | 0.330 |
Why?
|
Psychiatric Status Rating Scales | 18 | 2022 | 6029 | 0.330 |
Why?
|
Dopamine | 3 | 2017 | 1592 | 0.320 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 8 | 2018 | 1988 | 0.320 |
Why?
|
Social Adjustment | 2 | 2010 | 635 | 0.320 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 324 | 0.320 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26379 | 0.300 |
Why?
|
Psychomotor Disorders | 1 | 2009 | 149 | 0.300 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2748 | 0.300 |
Why?
|
Risk-Taking | 2 | 2013 | 1023 | 0.300 |
Why?
|
Anorexia Nervosa | 1 | 2017 | 1364 | 0.300 |
Why?
|
Attention | 6 | 2017 | 2424 | 0.280 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 984 | 0.280 |
Why?
|
Brain | 14 | 2022 | 27360 | 0.270 |
Why?
|
Executive Function | 7 | 2019 | 1401 | 0.260 |
Why?
|
Genetic Variation | 6 | 2017 | 6611 | 0.260 |
Why?
|
Haplotypes | 10 | 2011 | 2722 | 0.260 |
Why?
|
Genome-Wide Association Study | 15 | 2023 | 12795 | 0.260 |
Why?
|
Epistasis, Genetic | 1 | 2008 | 353 | 0.260 |
Why?
|
Reaction Time | 5 | 2021 | 2101 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2010 | 564 | 0.250 |
Why?
|
Institutionalization | 1 | 2005 | 108 | 0.240 |
Why?
|
Educational Status | 2 | 2019 | 2515 | 0.240 |
Why?
|
Adaptation, Psychological | 1 | 2016 | 2663 | 0.240 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1892 | 0.230 |
Why?
|
Child Abuse | 1 | 2013 | 1091 | 0.230 |
Why?
|
Ketamine | 2 | 2024 | 527 | 0.230 |
Why?
|
Aged | 29 | 2024 | 171504 | 0.220 |
Why?
|
Circadian Rhythm | 1 | 2015 | 2593 | 0.220 |
Why?
|
Young Adult | 23 | 2022 | 60066 | 0.220 |
Why?
|
Case-Control Studies | 16 | 2020 | 22291 | 0.220 |
Why?
|
Facial Expression | 3 | 2023 | 515 | 0.220 |
Why?
|
Psychometrics | 7 | 2017 | 3063 | 0.210 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1074 | 0.210 |
Why?
|
Self-Assessment | 1 | 2005 | 400 | 0.210 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2021 | 605 | 0.210 |
Why?
|
Focal Adhesions | 1 | 2023 | 113 | 0.210 |
Why?
|
Quality of Life | 2 | 2021 | 13490 | 0.200 |
Why?
|
Dystrophin-Associated Proteins | 5 | 2010 | 60 | 0.190 |
Why?
|
Marijuana Abuse | 3 | 2012 | 409 | 0.190 |
Why?
|
Mastocytosis | 1 | 2024 | 150 | 0.190 |
Why?
|
Phenotype | 6 | 2010 | 16726 | 0.190 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 4640 | 0.190 |
Why?
|
Adolescent | 26 | 2022 | 89169 | 0.190 |
Why?
|
Receptors, Dopamine | 2 | 2013 | 293 | 0.190 |
Why?
|
Piracetam | 1 | 2002 | 88 | 0.190 |
Why?
|
Temperament | 2 | 2014 | 301 | 0.190 |
Why?
|
Consensus | 5 | 2019 | 3212 | 0.190 |
Why?
|
Research Design | 4 | 2017 | 6211 | 0.180 |
Why?
|
Brain Mapping | 7 | 2020 | 6685 | 0.180 |
Why?
|
Double-Blind Method | 7 | 2021 | 12465 | 0.170 |
Why?
|
Neurogenesis | 2 | 2020 | 864 | 0.170 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2001 | 139 | 0.170 |
Why?
|
Mental Disorders | 4 | 2020 | 6874 | 0.170 |
Why?
|
Smoking | 1 | 2016 | 9092 | 0.170 |
Why?
|
Analysis of Variance | 5 | 2013 | 6229 | 0.160 |
Why?
|
Lithium Compounds | 2 | 2023 | 226 | 0.160 |
Why?
|
Amines | 1 | 2001 | 280 | 0.160 |
Why?
|
Severity of Illness Index | 12 | 2020 | 15948 | 0.160 |
Why?
|
Genomics | 2 | 2023 | 5926 | 0.150 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14783 | 0.150 |
Why?
|
Nervous System Diseases | 1 | 2009 | 1662 | 0.150 |
Why?
|
Serotonin Antagonists | 1 | 2018 | 147 | 0.150 |
Why?
|
Frontal Lobe | 4 | 2019 | 1426 | 0.150 |
Why?
|
Ondansetron | 1 | 2018 | 95 | 0.150 |
Why?
|
Anticonvulsants | 3 | 2023 | 1923 | 0.140 |
Why?
|
Cerebral Cortex | 5 | 2018 | 5812 | 0.140 |
Why?
|
Touch Perception | 1 | 2018 | 106 | 0.140 |
Why?
|
Statistics as Topic | 4 | 2017 | 2357 | 0.140 |
Why?
|
Multifactorial Inheritance | 4 | 2018 | 1422 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2048 | 0.140 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4423 | 0.140 |
Why?
|
Mental Health | 2 | 2022 | 3275 | 0.130 |
Why?
|
Aminopyridines | 1 | 2020 | 580 | 0.130 |
Why?
|
Self Report | 2 | 2018 | 3773 | 0.130 |
Why?
|
Intra-Abdominal Fat | 1 | 2021 | 625 | 0.130 |
Why?
|
Demography | 2 | 2019 | 1641 | 0.130 |
Why?
|
Thalamus | 4 | 2013 | 1047 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2008 | 370 | 0.130 |
Why?
|
Prefrontal Cortex | 4 | 2018 | 2238 | 0.130 |
Why?
|
Individuality | 1 | 2017 | 307 | 0.130 |
Why?
|
Aging | 5 | 2024 | 8744 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1418 | 0.130 |
Why?
|
Bulimia Nervosa | 1 | 2017 | 208 | 0.120 |
Why?
|
Alleles | 7 | 2023 | 6894 | 0.120 |
Why?
|
Central Nervous System Stimulants | 1 | 2024 | 1168 | 0.120 |
Why?
|
Regression Analysis | 4 | 2020 | 6340 | 0.120 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 1001 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2001 | 1141 | 0.110 |
Why?
|
Piperazines | 2 | 2020 | 2554 | 0.110 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 1752 | 0.110 |
Why?
|
Aggression | 1 | 2019 | 750 | 0.110 |
Why?
|
Games, Experimental | 1 | 2013 | 32 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1077 | 0.110 |
Why?
|
Ankyrins | 1 | 2013 | 123 | 0.110 |
Why?
|
Linear Models | 3 | 2020 | 5884 | 0.110 |
Why?
|
Risperidone | 3 | 2015 | 383 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1240 | 0.110 |
Why?
|
Anisotropy | 5 | 2019 | 1292 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1177 | 0.110 |
Why?
|
Irritable Mood | 1 | 2014 | 196 | 0.100 |
Why?
|
Developing Countries | 1 | 2005 | 2910 | 0.100 |
Why?
|
Disability Evaluation | 3 | 2016 | 1835 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2018 | 937 | 0.100 |
Why?
|
Calcium Channels, L-Type | 1 | 2013 | 244 | 0.100 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3729 | 0.100 |
Why?
|
Cerebrum | 1 | 2013 | 132 | 0.100 |
Why?
|
Intelligence Tests | 2 | 2012 | 504 | 0.100 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2011 | 26 | 0.090 |
Why?
|
Reward | 2 | 2019 | 981 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 41754 | 0.090 |
Why?
|
Child | 11 | 2020 | 80917 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1462 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2021 | 65371 | 0.090 |
Why?
|
Receptors, Glutamate | 1 | 2011 | 229 | 0.090 |
Why?
|
Survivors | 1 | 2021 | 2381 | 0.090 |
Why?
|
Dopamine Agents | 1 | 2011 | 188 | 0.090 |
Why?
|
Chicago | 1 | 2010 | 255 | 0.090 |
Why?
|
Outpatients | 2 | 2016 | 1600 | 0.090 |
Why?
|
Homozygote | 3 | 2015 | 1779 | 0.090 |
Why?
|
Gambling | 3 | 2007 | 192 | 0.080 |
Why?
|
Corpus Callosum | 1 | 2014 | 753 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2014 | 2815 | 0.080 |
Why?
|
Wechsler Scales | 2 | 2008 | 256 | 0.080 |
Why?
|
Antimanic Agents | 2 | 2023 | 524 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 13 | 2022 | 36743 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2566 | 0.080 |
Why?
|
Disease Progression | 2 | 2022 | 13671 | 0.080 |
Why?
|
Marijuana Smoking | 1 | 2012 | 261 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1095 | 0.080 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2011 | 417 | 0.080 |
Why?
|
Genetic Markers | 4 | 2009 | 2603 | 0.080 |
Why?
|
Origin Recognition Complex | 1 | 2008 | 20 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4352 | 0.080 |
Why?
|
Risk Factors | 11 | 2020 | 74944 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.080 |
Why?
|
Personality Inventory | 1 | 2011 | 1018 | 0.080 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2008 | 127 | 0.070 |
Why?
|
Advisory Committees | 3 | 2019 | 797 | 0.070 |
Why?
|
Thiazoles | 2 | 2006 | 1542 | 0.070 |
Why?
|
Genetic Loci | 4 | 2018 | 2629 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 507 | 0.070 |
Why?
|
Valine | 1 | 2009 | 410 | 0.070 |
Why?
|
Gene Frequency | 3 | 2017 | 3623 | 0.070 |
Why?
|
Binding, Competitive | 1 | 2008 | 1142 | 0.070 |
Why?
|
Motivation | 2 | 2020 | 2020 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2008 | 452 | 0.070 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2006 | 108 | 0.070 |
Why?
|
Valproic Acid | 2 | 2016 | 444 | 0.060 |
Why?
|
Penetrance | 1 | 2007 | 385 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2017 | 4249 | 0.060 |
Why?
|
Benzodiazepines | 2 | 2008 | 1138 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2008 | 553 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10873 | 0.060 |
Why?
|
Genes, Recessive | 1 | 2007 | 625 | 0.060 |
Why?
|
Mental Status Schedule | 1 | 2005 | 315 | 0.060 |
Why?
|
Age Factors | 5 | 2020 | 18412 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2012 | 1726 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4819 | 0.060 |
Why?
|
Psychological Tests | 1 | 2007 | 643 | 0.060 |
Why?
|
Sex Factors | 3 | 2013 | 10632 | 0.060 |
Why?
|
Remission Induction | 2 | 2024 | 2410 | 0.060 |
Why?
|
Prospective Studies | 3 | 2022 | 54926 | 0.060 |
Why?
|
Delusions | 1 | 2006 | 300 | 0.060 |
Why?
|
Employment | 1 | 2010 | 1110 | 0.060 |
Why?
|
Linkage Disequilibrium | 2 | 2008 | 1997 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 4938 | 0.060 |
Why?
|
Comorbidity | 3 | 2022 | 10590 | 0.060 |
Why?
|
Hallucinations | 1 | 2006 | 373 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15869 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 6316 | 0.050 |
Why?
|
DNA Replication | 1 | 2010 | 1427 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 638 | 0.050 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20227 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39348 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2330 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 143 | 0.050 |
Why?
|
Cerebellum | 1 | 2009 | 1522 | 0.050 |
Why?
|
Brazil | 1 | 2005 | 1250 | 0.050 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1363 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2909 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.040 |
Why?
|
Perimenopause | 1 | 2021 | 142 | 0.040 |
Why?
|
Nerve Net | 2 | 2013 | 2352 | 0.040 |
Why?
|
Carbamazepine | 1 | 2001 | 224 | 0.040 |
Why?
|
Repression, Psychology | 1 | 2020 | 46 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 3 | 2019 | 2420 | 0.040 |
Why?
|
Methylphenidate | 1 | 2024 | 480 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1265 | 0.040 |
Why?
|
Taiwan | 1 | 2020 | 521 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2018 | 81762 | 0.040 |
Why?
|
Acetates | 1 | 2001 | 317 | 0.040 |
Why?
|
Neural Pathways | 4 | 2012 | 3117 | 0.040 |
Why?
|
Blinking | 1 | 2020 | 135 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2024 | 2230 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 13090 | 0.040 |
Why?
|
Triazines | 1 | 2001 | 311 | 0.040 |
Why?
|
Fructose | 1 | 2001 | 284 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8509 | 0.040 |
Why?
|
Risk | 2 | 2013 | 9613 | 0.040 |
Why?
|
Personality | 1 | 2022 | 559 | 0.040 |
Why?
|
Early Diagnosis | 2 | 2017 | 1194 | 0.040 |
Why?
|
Cefotaxime | 1 | 2017 | 36 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2010 | 3721 | 0.040 |
Why?
|
Societies, Medical | 1 | 2010 | 3968 | 0.040 |
Why?
|
Internal Capsule | 1 | 2019 | 138 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 14164 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2006 | 2783 | 0.040 |
Why?
|
Gene Duplication | 1 | 2018 | 315 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2004 | 4860 | 0.040 |
Why?
|
Sleep, REM | 1 | 2020 | 595 | 0.040 |
Why?
|
Cognitive Reserve | 1 | 2018 | 92 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1518 | 0.030 |
Why?
|
Psychopathology | 1 | 2019 | 434 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2744 | 0.030 |
Why?
|
Age of Onset | 3 | 2007 | 3347 | 0.030 |
Why?
|
Somatosensory Cortex | 1 | 2018 | 516 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15454 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15597 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2267 | 0.030 |
Why?
|
Patient Participation | 1 | 2022 | 1447 | 0.030 |
Why?
|
Midazolam | 1 | 2015 | 267 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10760 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11928 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1436 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2013 | 391 | 0.020 |
Why?
|
Models, Neurological | 2 | 2009 | 1776 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59629 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1887 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7243 | 0.020 |
Why?
|
Stroop Test | 1 | 2010 | 72 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 9015 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2131 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2016 | 1474 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 812 | 0.020 |
Why?
|
Achievement | 1 | 2010 | 288 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2010 | 336 | 0.020 |
Why?
|
Schizophrenic Language | 1 | 2008 | 57 | 0.020 |
Why?
|
CHO Cells | 1 | 2011 | 1379 | 0.020 |
Why?
|
Synapses | 1 | 2017 | 1765 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 577 | 0.020 |
Why?
|
Probability | 1 | 2013 | 2479 | 0.020 |
Why?
|
Lod Score | 1 | 2008 | 600 | 0.020 |
Why?
|
Pons | 1 | 2009 | 242 | 0.020 |
Why?
|
Face | 1 | 2013 | 1029 | 0.020 |
Why?
|
Control Groups | 1 | 2007 | 107 | 0.020 |
Why?
|
Cricetinae | 1 | 2011 | 2423 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4620 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1606 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9538 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2536 | 0.020 |
Why?
|
Functional Laterality | 1 | 2013 | 2264 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4260 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2009 | 4063 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2013 | 2359 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10399 | 0.020 |
Why?
|
Epilepsy | 1 | 2001 | 3327 | 0.020 |
Why?
|
Electroencephalography | 1 | 2020 | 6314 | 0.010 |
Why?
|
Anxiety | 1 | 2020 | 4672 | 0.010 |
Why?
|
Prolactin | 1 | 2006 | 627 | 0.010 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2006 | 267 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9514 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2008 | 877 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13014 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2342 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3436 | 0.010 |
Why?
|
Serine | 1 | 2006 | 831 | 0.010 |
Why?
|
Interview, Psychological | 1 | 2005 | 810 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4446 | 0.010 |
Why?
|
Motor Skills | 1 | 2005 | 523 | 0.010 |
Why?
|
Space Perception | 1 | 2005 | 466 | 0.010 |
Why?
|
Personality Assessment | 1 | 2004 | 646 | 0.010 |
Why?
|
Cysteine | 1 | 2006 | 897 | 0.010 |
Why?
|
Family | 1 | 2012 | 3209 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26422 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5107 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3800 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 30010 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1448 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40218 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9343 | 0.010 |
Why?
|
Hippocampus | 1 | 2011 | 3785 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36535 | 0.010 |
Why?
|
Forecasting | 1 | 2007 | 2945 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1599 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
Memory | 1 | 2006 | 2208 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19015 | 0.010 |
Why?
|
Language | 1 | 2005 | 1557 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2709 | 0.010 |
Why?
|
Animals | 3 | 2011 | 169246 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22379 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7852 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24315 | 0.010 |
Why?
|
Pilot Projects | 1 | 2004 | 8741 | 0.010 |
Why?
|
Mice | 1 | 2011 | 82029 | 0.000 |
Why?
|